P Maes1, B Brichard, C Vermylen, G Cornu, J Ninane. 1. Department of Pediatric Hematology and Oncology, Cliniques Universitaires Saint-Luc, Catholic University of Brussels, Belgium.
Abstract
BACKGROUND: Osteosarcoma of the head and neck, especially primary forms, remains a rare and highly malignant tumor. PATIENTS: This report describes two patients who developed an osteosarcoma of the face more than ten years after treatment for bilateral retinoblastoma. We also report a third patient who presented with a primary osteosarcoma of the right superior maxilla which is one of the rarest tumors encountered in childhood oncology. CONCLUSIONS: The mainstay of therapy is surgical resection with negative margins. Careful, long-term follow-up of survivors of hereditary retinoblastoma is essential, especially for those given radiation therapy.
BACKGROUND:Osteosarcoma of the head and neck, especially primary forms, remains a rare and highly malignant tumor. PATIENTS: This report describes two patients who developed an osteosarcoma of the face more than ten years after treatment for bilateral retinoblastoma. We also report a third patient who presented with a primary osteosarcoma of the right superior maxilla which is one of the rarest tumors encountered in childhood oncology. CONCLUSIONS: The mainstay of therapy is surgical resection with negative margins. Careful, long-term follow-up of survivors of hereditary retinoblastoma is essential, especially for those given radiation therapy.
Authors: Marta E Gonzalez; Prashant Raghavan; Benjamin Cho; Thomas Jose Eluvathingal Muttikkal; Patrice K Rehm Journal: J Radiol Case Rep Date: 2016-02-29
Authors: Youn Jeong Kim; Yeo Ju Kim; Young Chae Chu; Ju Won Lee; Yong Sun Jeon; Kyung-Hee Lee; Soon Gu Cho; Mi Young Kim Journal: Clin Exp Otorhinolaryngol Date: 2011-09-15 Impact factor: 3.372
Authors: V Minard-Colin; C Kalifa; J-M Guinebretiere; L Brugieres; J Dubousset; J-L Habrand; G Vassal; O Hartmann Journal: Br J Cancer Date: 2004-02-09 Impact factor: 7.640